To see the press release which announced this change, go to the Office of Public Sector Information website (opens in a new window)
A review on BPC-157 and gastric cytoprotection describes it as a stable gastric pentadecapeptide with anti-ulcer and tissue-protective effects and notes that it has been used in trials for ulcerative colitis
Compounded GLP-1 therapy allows providers to customize dosages, combine ingredients to mitigate side effects (such as adding B12 for nausea), and maintain consistent patient access, provided they use heavily vetted, highly regulated pharmacy partners
Daily dose: 1,165mcg (1.165mg) total blend This breaks down to approximately: 850mcg GHK-Cu 165mcg TB-500 165mcg BPC-157 Administration: Once daily, subcutaneous injection Cycle length: 4 weeks initial assessment Schedule: Daily injection at a consistent time, preferably morning At this dose level, you're working with approximately half the standard protocol
Secure Checkout On orders over $200 Money-back guarantee Get 2 day shipping when you spend $250 or More Free shipping over $200 60-day money back SSL Secure Discreet packaging Every batch verified by accredited US labs Every order fully covered No questions asked Each component within the KLOW Blend formulation is verified through independent analytical testing to confirm identity, purity, and structural consistency
